<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Brain</journal-id>
<journal-id journal-id-type="iso-abbrev">Brain</journal-id>
<journal-id journal-id-type="publisher-id">brainj</journal-id>
<journal-title-group>
<journal-title>Brain</journal-title>
</journal-title-group>
<issn pub-type="ppub">0006-8950</issn>
<issn pub-type="epub">1460-2156</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28969385</article-id>
<article-id pub-id-type="pmc">6080423</article-id>
<article-id pub-id-type="doi">10.1093/brain/awx203</article-id>
<article-id pub-id-type="publisher-id">awx203</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
<subj-group subj-group-type="category-oup-series">
<subject>Editor's Choice</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Mutations of <italic>AKT3</italic> are associated with a wide spectrum of developmental disorders including extreme megalencephaly</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Alcantara</surname>
<given-names>Diana</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Timms</surname>
<given-names>Andrew E</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gripp</surname>
<given-names>Karen</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF3">3</xref>
<xref ref-type="aff" rid="awx203-AFF4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baker</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF3">3</xref>
<xref ref-type="aff" rid="awx203-AFF4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Park</surname>
<given-names>Kaylee</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Collins</surname>
<given-names>Sarah</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cheng</surname>
<given-names>Chi</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stewart</surname>
<given-names>Fiona</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mehta</surname>
<given-names>Sarju G</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saggar</surname>
<given-names>Anand</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sztriha</surname>
<given-names>László</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zombor</surname>
<given-names>Melinda</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Caluseriu</surname>
<given-names>Oana</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mesterman</surname>
<given-names>Ronit</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Van Allen</surname>
<given-names>Margot I</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF12">12</xref>
<xref ref-type="aff" rid="awx203-AFF13">13</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jacquinet</surname>
<given-names>Adeline</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF14">14</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ygberg</surname>
<given-names>Sofia</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF15">15</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bernstein</surname>
<given-names>Jonathan A</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF16">16</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wenger</surname>
<given-names>Aaron M</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF16">16</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guturu</surname>
<given-names>Harendra</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF16">16</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bejerano</surname>
<given-names>Gill</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF16">16</xref>
<xref ref-type="aff" rid="awx203-AFF17">17</xref>
<xref ref-type="aff" rid="awx203-AFF18">18</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gomez-Ospina</surname>
<given-names>Natalia</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF16">16</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lehman</surname>
<given-names>Anna</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alfei</surname>
<given-names>Enrico</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF19">19</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pantaleoni</surname>
<given-names>Chiara</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF19">19</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Conti</surname>
<given-names>Valerio</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF20">20</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guerrini</surname>
<given-names>Renzo</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF20">20</xref>
<xref ref-type="aff" rid="awx203-AFF21">21</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moog</surname>
<given-names>Ute</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF22">22</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Graham Jr.</surname>
<given-names>John M</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF23">23</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hevner</surname>
<given-names>Robert</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF5">5</xref>
<xref ref-type="aff" rid="awx203-AFF24">24</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dobyns</surname>
<given-names>William B</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF5">5</xref>
<xref ref-type="aff" rid="awx203-AFF25">25</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>O’Driscoll</surname>
<given-names>Mark</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mirzaa</surname>
<given-names>Ghayda M</given-names>
</name>
<xref ref-type="aff" rid="awx203-AFF5">5</xref>
<xref ref-type="aff" rid="awx203-AFF25">25</xref>
<xref ref-type="corresp" rid="COR1"></xref>
<!--<email>gmirzaa@uw.edu</email>-->
</contrib>
</contrib-group>
<aff id="awx203-AFF1"><label>1</label>Genome Damage and Stability Centre, University of Sussex, Sussex, UK</aff>
<aff id="awx203-AFF2"><label>2</label>Center for Developmental Biology and Regenerative Medicine, Seattle Children’s Research Institute, Seattle, WA, USA</aff>
<aff id="awx203-AFF3"><label>3</label>Department of Pediatrics, Sidney Kimmel Medical School, Thomas Jefferson University, Philadelphia, Pennsylvania, USA</aff>
<aff id="awx203-AFF4"><label>4</label>Division of Medical Genetics, A.I. duPont Hospital for Children, Wilmington, Delaware, USA</aff>
<aff id="awx203-AFF5"><label>5</label>Center for Integrative Brain Research, Seattle Children’s Research Institute, Seattle, Washington, USA</aff>
<aff id="awx203-AFF6"><label>6</label>Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK</aff>
<aff id="awx203-AFF7"><label>7</label>East Anglian Medical Genetics Service, Addenbrookes Hospital, Cambridge, UK</aff>
<aff id="awx203-AFF8"><label>8</label>South West Thames Regional Genetic Services, St. George’s NHS Trust and St. George’s Hospital Medical School, London, UK</aff>
<aff id="awx203-AFF9"><label>9</label>Department of Pediatrics, University of Szeged, Szeged, Hungary</aff>
<aff id="awx203-AFF10"><label>10</label>Department of Medical Genetics, Department of Pediatrics, University of Alberta, Edmonton, AB, Canada</aff>
<aff id="awx203-AFF11"><label>11</label>Division of Pediatric Neurology, Developmental Pediatric Rehabilitation and Autism Spectrum Disorder, McMaster University, Hamilton, ON, Canada</aff>
<aff id="awx203-AFF12"><label>12</label>Department of Medical Genetics, University of British Columbia, Vancouver, Canada</aff>
<aff id="awx203-AFF13"><label>13</label>B.C. Children’s Hospital Research Centre, Vancouver, BC Canada</aff>
<aff id="awx203-AFF14"><label>14</label>Center for Human Genetics, Centre Hospitalier Universitaire and University of Liège, Liège, Belgium</aff>
<aff id="awx203-AFF15"><label>15</label>Neuropediatric Unit and Centre for Inherited Metabolic Diseases (CMMS), Karolinska University Hospital, Stockholm, Sweden</aff>
<aff id="awx203-AFF16"><label>16</label>Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA</aff>
<aff id="awx203-AFF17"><label>17</label>Department of Computer Science, School of Engineering, Stanford University School of Medicine, Stanford, California, USA</aff>
<aff id="awx203-AFF18"><label>18</label>Department of Developmental Biology, School of Medicine, Stanford University School of Medicine, Stanford, California, USA</aff>
<aff id="awx203-AFF19"><label>19</label>Developmental Neurology Unit, Department of Pediatric Neurosciences, Carlo Besta Neurological Institute, IRCCS Foundation, Milan, Italy</aff>
<aff id="awx203-AFF20"><label>20</label>Pediatric Neurology, Neurogenetics and Neurobiology Unit and Laboratories, A. Meyer Children’s Hospital, Florence, Italy</aff>
<aff id="awx203-AFF21"><label>21</label>IRCCS Stella Maris, Pisa, Italy</aff>
<aff id="awx203-AFF22"><label>22</label>Institute of Human Genetics, Heidelberg University, Heidelberg, Germany</aff>
<aff id="awx203-AFF23"><label>23</label>Department of Pediatrics, Cedars-Sinai Medical Center, Harbor-UCLA Medical Center, David Geffen School of Medicine Los Angeles, California, USA</aff>
<aff id="awx203-AFF24"><label>24</label>Department of Neurological Surgery, University of Washington, Seattle, Washington, USA</aff>
<aff id="awx203-AFF25"><label>25</label>Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, Washington, USA</aff>
<author-notes>
<corresp id="COR1">Correspondence to: Ghayda Mirzaa, M.D., Center for Integrative Brain Research, Seattle Children’s Research Institute, 1900 9th Avenue, Mailstop C9S-10, Seattle, WA, USA E-mail: <email>gmirzaa@uw.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date iso-8601-date="2017-09-07" pub-type="epub">
<day>07</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>10</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>140</volume>
<issue>10</issue>
<fpage>2610</fpage>
<lpage>2622</lpage>
<history>
<date date-type="received">
<day>27</day>
<month>4</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>13</day>
<month>6</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>4</day>
<month>7</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author (2017). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<self-uri xlink:href="awx203.pdf"></self-uri>
<abstract abstract-type="teaser">
<p>Malformations of cortical development are associated with significant morbidity and mortality. Alcantara <italic>et al.</italic> report that mosaic and constitutional mutations of the <italic>AKT3</italic> gene are associated with a wide spectrum of brain disorders including focal and bilateral cortical malformations, diffuse megalencephaly and autism spectrum disorders.</p>
</abstract>
<abstract>
<title>Abstract</title>
<p>Mutations of genes within the phosphatidylinositol-3-kinase (PI3K)-AKT-MTOR pathway are well known causes of brain overgrowth (megalencephaly) as well as segmental cortical dysplasia (such as hemimegalencephaly, focal cortical dysplasia and polymicrogyria). Mutations of the <italic>AKT3</italic> gene have been reported in a few individuals with brain malformations, to date. Therefore, our understanding regarding the clinical and molecular spectrum associated with mutations of this critical gene is limited, with no clear genotype–phenotype correlations. We sought to further delineate this spectrum, study levels of mosaicism and identify genotype–phenotype correlations of <italic>AKT3</italic>-related disorders. We performed targeted sequencing of <italic>AKT3</italic> on individuals with these phenotypes by molecular inversion probes and/or Sanger sequencing to determine the type and level of mosaicism of mutations. We analysed all clinical and brain imaging data of mutation-positive individuals including neuropathological analysis in one instance. We performed <italic>ex vivo</italic> kinase assays on AKT3 engineered with the patient mutations and examined the phospholipid binding profile of pleckstrin homology domain localizing mutations. We identified 14 new individuals with <italic>AKT3</italic> mutations with several phenotypes dependent on the type of mutation and level of mosaicism. Our comprehensive clinical characterization, and review of all previously published patients, broadly segregates individuals with <italic>AKT3</italic> mutations into two groups: patients with highly asymmetric cortical dysplasia caused by the common p.E17K mutation, and patients with constitutional <italic>AKT3</italic> mutations exhibiting more variable phenotypes including bilateral cortical malformations, polymicrogyria, periventricular nodular heterotopia and diffuse megalencephaly without cortical dysplasia. All mutations increased kinase activity, and pleckstrin homology domain mutants exhibited enhanced phospholipid binding. Overall, our study shows that activating mutations of the critical <italic>AKT3</italic> gene are associated with a wide spectrum of brain involvement ranging from focal or segmental brain malformations (such as hemimegalencephaly and polymicrogyria) predominantly due to mosaic <italic>AKT3</italic> mutations, to diffuse bilateral cortical malformations, megalencephaly and heterotopia due to constitutional <italic>AKT3</italic> mutations. We also provide the first detailed neuropathological examination of a child with extreme megalencephaly due to a constitutional <italic>AKT3</italic> mutation. This child has one of the largest documented paediatric brain sizes, to our knowledge. Finally, our data show that constitutional <italic>AKT3</italic> mutations are associated with megalencephaly, with or without autism, similar to <italic>PTEN</italic>-related disorders. Recognition of this broad clinical and molecular spectrum of <italic>AKT3</italic> mutations is important for providing early diagnosis and appropriate management of affected individuals, and will facilitate targeted design of future human clinical trials using PI3K-AKT pathway inhibitors.</p>
</abstract>
<kwd-group kwd-group-type="keywords">
<kwd>
<italic>AKT3</italic>
</kwd>
<kwd>megalencephaly</kwd>
<kwd>polymicrogyria</kwd>
<kwd>hemimegalencephaly</kwd>
<kwd>epilepsy</kwd>
</kwd-group>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institute of Neurological Disorders and Stroke (NINDS)</named-content>
<named-content content-type="funder-identifier">10.13039/100000065</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Heart, Lung and Blood Institute (NHLBI)</named-content>
<named-content content-type="funder-identifier">10.13039/100000050</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institutes of Health (NIH)</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
<award-id>K08NS092898</award-id>
<award-id>R01NS092772</award-id>
<award-id>R01HL130996</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">Cancer Research UK Programme award</named-content>
</funding-source>
<award-id>C24110/A15394</award-id>
<award-id>N602531</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="13"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>